CIK 0001563665 · Non-accelerated filer<br>Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455210462
- Phone
- (774) 233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- Open-market buys, last 90 days
- $394,459
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$394,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-07 | Yu Hong PRESIDENT | Sale | −83,676 | $7.17 | $600K | 222,459 |
| 2022-12-07 | Yu Hong PRESIDENT | Option exercise · Warrants (right to buy) | −300,000 | 0 | ||
| 2022-12-07 | Chen Jing Director | Option exercise | +174,000 | $2.00 | $348K | 210,000 |
| 2022-12-07 | Chen Jing Director | Sale | −48,532 | $7.17 | $348K | 161,468 |
| 2022-12-07 | Chen Jing Director | Option exercise · Warrants (right to buy) | −174,000 | 0 | ||
| 2022-08-08 | DAMASIO JOSEPH LUIS JR Chief Financial Officer | Grant or award · Stock Option (right to buy) | +116,156 | 116,156 | ||
| 2022-06-29 | Shmerling James E. Director | Grant or award · Stock Option (right to buy) | +6,241 | 6,241 | ||
| 2022-06-29 | Shmerling James E. Director | Grant or award · Stock Option (right to buy) | +5,016 | 5,016 | ||
| 2022-06-29 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +6,241 | 6,241 | ||
| 2022-06-29 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +5,016 | 5,016 | ||
| 2022-06-29 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +6,241 | 6,241 | ||
| 2022-06-29 | Chen Jing Director | Grant or award · Stock Option (right to buy) | +5,016 | 5,016 | ||
| 2022-06-29 | Li Ting Director | Grant or award · Stock Option (right to buy) | +6,241 | 6,241 | ||
| 2022-06-29 | Li Ting Director | Grant or award · Stock Option (right to buy) | +5,016 | 5,016 | ||
| 2022-06-29 | He Junli Director | Grant or award · Stock Option (right to buy) | +6,241 | 6,241 | ||
| 2022-06-29 | He Junli Director | Grant or award · Stock Option (right to buy) | +5,016 | 5,016 | ||
| 2022-05-18 | He Junli Director | Grant or award · Stock Option (right to buy) | +6,813 | 6,813 | ||
| 2022-05-18 | Yu Hong President | Grant or award · Stock Option (right to buy) | +22,089 | 22,089 | ||
| 2022-05-12 | Shmerling James E. Director | Purchase | +16,892 | $5.92 | $100K | 16,892 |
| 2022-05-12 | Shmerling James E. Director | Purchase · Warrants (right to buy) | +8,446 | 8,446 |
Page 5 of 10 · 182 trades